Biography of Anna Protopapas
Last update: February 10, 2024Career
Anna was President at Millennium, and Executive Vice President, and Corporate Officer, Global Licensing and Business Development at Takeda Pharmaceuticals.
Anna Protopapas is currently- Chairman of the Board at Nuvalent - View - Nuvalent org chart
- Director at Mersana Therapeutics - View - Mersana Therapeutics org chart
Create your alert
to follow the career of Anna Protopapas.
Education
Anna Protopapas has a Master of Science in Engineering and Chemical Engineering from Massachusetts Institute of Technology and a Master of Business Administration from Stanford Business School.
They have also studied at Massachusetts Institute of Technology :
Find more alumni from Massachusetts Institute of Technology
They have also studied at Stanford Business School :
Find more alumni from Stanford Business School
More about Anna Protopapas
Selected links
Do you need to know more about Anna Protopapas? More results.
Participate
Social media
- Anna Protopapas on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Anna Protopapas
The colleagues of Anna Protopapas
Company Colleagues
- At Nuvalent, Anna Protopapas has 50 colleagues including James Porter (CEO), Matthew Shair (Director)…
- At Mersana Therapeutics, Anna Protopapas has 18 colleagues including Martin Huber (CEO & Director), Kristen Hege (Director)…
Industry Colleagues
- In the Biotechnology industry, Anna Protopapas has 30,203 colleagues in 2,276 companies located in 40 countries. 14,242 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Anna Protopapas.
Get in Touch
and ask for Anna Protopapas.
